Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients
Alzheimer's disease (AD) is characterized by the presence of proteinaceous brain deposits, brain atrophy, vascular dysfunction, and chronic inflammation. Along with cerebral inflammation, peripheral inflammation is also evident in many AD patients. Bradykinin, a proinflammatory plasma peptide,...
Main Authors: | Pradeep K. Singh, Zu-Lin Chen, Dhiman Ghosh, Sidney Strickland, Erin H. Norris |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096999612030108X |
Similar Items
-
A novel detection method of cleaved plasma high‐molecular‐weight kininogen reveals its correlation with Alzheimer's pathology and cognitive impairment
by: Hitomi Yamamoto‐Imoto, et al.
Published: (2018-01-01) -
Lisinopril-Induced Angioedema in a Patient with Plasma Prekallikrein Deficiency
by: Swapan K. Dasgupta, et al.
Published: (2020-01-01) -
A Review on Bradykinin-Related Peptides Isolated from Amphibian Skin Secretion
by: Xinping Xi, et al.
Published: (2015-03-01) -
The blood fluke Schistosoma mansoni cleaves the coagulation protein high molecular weight kininogen (HK) but does not generate the vasodilator bradykinin
by: Qiang Wang, et al.
Published: (2018-03-01) -
Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides
by: D.J. Campbell
Published: (2000-06-01)